埃索美拉唑在消化道疾病中的应用

, PP. 541-543

Keywords: 埃索美拉唑,消化道疾病,幽门螺杆菌

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Tulassay Z. One week of treatment with esomprazole-based triple therap y eradi cates Helicobacter pylori and heals patients with duodenal ulcer disease[J]. Eur J Gastroenterol Hepatol,2001,13(12):1457-1465.
[2]	Veldhuyzen Van Zanten S,Machado S,Lee J.One-week triple therapy with esomepra zole,clarithromycin and metronidazole provides effective eradication of Helicob acter pylori infection[J].Aliment Pharmacol Ther,2003,17(11):1381-1387.
[3]	Richter JE,Kahrilas PJ,JohansonJ,et al.Efficacy and safety of esomep razole co mpared with omeprazole in GERD patients with erosive esophagitis:a randomized controlled trial[J].Am J Gassrroenterol,2001,96:656-665.
[4]	Castell DO,Kahrilas PJ,Richter JE,et al.Esomeprazole(40mg)compare d with lan soprazole(30mg)in the treatment of erosive esophagitis[J].Am J Gastroenterol ,2002,97:575-583.
[5]	Labenz J.Esomeprazole 40mg heals significantly more Heilcobacter pylori -negat ive erosive esophatitis patients than pantoprazole 40mg[C]. New Orleans.Post er presented at Digestive Diseases Week congeress,2004.
[6]	Robindo M. Review article:the pharmacodynamics andph-armacokinetics of proton pump inhibitors overview and clinical implications [J]. Aliment Pharmacol Ther,2004,20(Supplement):1-10.
[7]	Abelo A.Stereoselective metabolism of omeprazole P450 enzymes[J].Drug Metab Dispos,2000,28:966-972.
[8]	Lina T.Esomeprazole provides improved acid controlvs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease[J ].Aliment Pharmacol Ther,2000,14:861-867.
[9]	许国铭,钟捷.质子泵抑制剂-基础与临床[M].上海:上海科技教育出版社,2004:24.
[10]	甚先保,李兆申,程能能,等.埃索美拉唑对健康志愿者抑制胃泌酸的药效学研究[J].中华消化杂志,2004,24(12):711-714.
[11]	Miner P. Gastric acid control with esomeprazole,lansoprazole,omeprazol e,pan toprazole,andrabeprazole:a five-way crossover study[J]. Am J Gastroenterol ,2003,98(12):2616-2620.
[12]	Miehlke S,Madisch A,Kirsh C,et al.Intragastric acidity duringtreatment with esomeprazole 40mg twice daily or pantoprazole 40mg twice daily-a randomized,two-way crossover study[J]. Aliment Pharmacol Ther,2005,21(8): 963-967.
[13]	李瑜元.酸相关疾病治疗的抑酸水平及药物选择[J]. 中华消化杂志,2001,21( 11):645-646.
[14]	Johnson DA. Review of esomeprazole(Nexium)in the treatment of acid disor ders[J].Expert Opin Pharmacother,2003,4(2):253-264.
[15]	Katz PO,Castell DO,Chen Y,et al.Intragzstric acid suppression andpharmacokinetics of twice-daily esomeprazole:a randomized,three-way crossover study[J].Aliment Pharmacol Ther,2004,15,20(4):399-406.
[16]	Lindberg P,Keeling D,Fryklund J,et al. Review article:Esomeprazole- enhanced bio-availability,specificity for the proton pump and inhibition of acid secret ion[J].Aliment Pharmacol Ther,2003,17(4):481-488.
[17]	Hammer J,Schmidet B.Effect of esomeprazole on gastric acidity and noct urna l acid breakthrough[J].Aliment Pharmacol Ther,2004,19(10):1105-10.
[18]	Gisbert JP,Dominguez-Munoz A,Gisbert JL,et al. Esomeprazole-based th erapy i n helicobacter pylori eradication:any effect by increasing the dose of esomepr azole or prolonging the treatment?[J].Am J Gastroenterol,2005,100:1935- 194 0.
[19]	Veldhuyzen Van Zanten S,Lauritsen K,Delchri JC,et al. One-week triple therz py with esomeprazole provides effective eradication of Helicobacter pylori in du odenal ulcer disease[J].Aliment Pharnacol Ther,2001,14(12):1605-1612.
[20]	Rohss.Esomprazole 40mg provides more effective intragastric acid contr ol tha n lansoprazole 30mg,omeprazole 20mg,pantoprazole 40mg snd rabeprazole 20mg in patients with gastro -oesophageal reflux sympotoms[J].Eur J Clin Pharmacol, 2004,60:531-539.
[21]	Lauritsen K.Esomeprazole 20mg and lansoprazole 15mg in maintaining he aled re flux oesophagitis:Metropole study results[J].Aliment Pharmacol Ther,2003, 17:333-341.
[22]	Deviere J,Bigard MA,Bayerdorffer E,et al. Esomeprazole 20mg And Lans oprazol e15mg in maintaining healed reflux oesophagitis:Metropole study results[J].A liment Pharmacol Ther,2003,17(Suppl 1):25-27.
[23]	Dent J.Review article:Initial therapy of reflux disease with esomepraz ole[J].Aliment Pharmacol Ther,2003,17(Suppl 1):18-20.
[24]	Vakil N. Review article:esomeprazole,40mg once daily,compared with l ansopra zole,30mg once daily,in healing and symptom resolution of erosive oesophagiti s[J].Aliment Pharmacol Ther,2003,17(Suppl 1):21-23.
[25]	Armstrong D,Talley NJ,Lauritsen K,et al.The role of acid suppression in pati ents with endoscopy-negative reflux disease:the effect of treatment with esomep razole or omeprazole[J].Aliment Pharmacol Ther,2004,20(4):413-421.
[26]	Tsai HH,Chapman R,Shepherd A,et al.Command Study Group Esomeprazole 20mg on- demand is more acceptable to patients than continuous lansoprazole 15mg in the l ong-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the Command Study[J].Alimient Pharmacol Ther,2004,20(6):657-665.
[27]	Chris Hawkey,Nicholas J Talley,Neville D Yeomans.Improvements with es omeprazo le in patients with upper gastrointestinal symptoms taking nonsteroidal anti-inf lammatory drugs,including selective cox-2 inhibitors[J].Am J Gastroenterol, 2005,100:1028-1036.
[28]	Genta RM.Safety of long-term treatment with a new PPI,esomeprazole in GERD patients[J]. Gastroenterology,2000,118(Suppl 2):A 16.

Full-Text